News &amp; Updates

While older recipients of living donor liver transplantation (LDLT) appear to suffer from worse mortality outcomes, such deficiency may be attributable to clinical confounders, a recent study has found. In controlled analysis, older and younger patients show comparable long-term survival following LDLT.

Age does not affect survival after liver transplant

Delayed tacrolimus dose reduction plus basiliximab yields better kidney function after liver transplant

A delayed dose reduction of tacrolimus, along with induction of basiliximab, helps suppress kidney injury in liver transplant recipients, as opposed to standard-dose tacrolimus, a recent study has found. Such benefits come with no excess risk of rejection, graft loss, or death.

Delayed tacrolimus dose reduction plus basiliximab yields better kidney function after liver transplant

Lower risk of SARS-CoV-2 after booster dose

03 Jan 2022 by

Receipt of a booster dose of the BNT162b2 mRNA vaccine is tied to a reduced risk of testing positive for SARS-CoV-2, according to results of a study from Israel.

Lower risk of SARS-CoV-2 after booster dose

Magnesium deficiency may be indicator of prediabetes

People with prediabetes seem to have lower circulating levels of serum magnesium than healthy counterparts, a new meta-analysis has found, suggesting that magnesium deficiency may be an easy indicator of prediabetes risk.

Magnesium deficiency may be indicator of prediabetes

Vitamin A supplement reduces bronchopulmonary dysplasia risk in very-preterm infants

Supplementation with vitamin A reduces the risk of bronchopulmonary dysplasia (BPD) in very-low-birthweight (VLBW) infants, but the benefit appears to be limited to those with baseline intake <1,500 IU · kg−1 · d−1 and is not affected by the administration route, a study has found.

Vitamin A supplement reduces bronchopulmonary dysplasia risk in very-preterm infants

Breast cancer survivors at greater risk of non-Hodgkin lymphoma

Exacerbation history, along with the presence of severe dyspnoea and maintenance treatment use, is associated with an increased risk of future exacerbation episodes in patients with chronic obstructive pulmonary disease, a study has found.

Non-Hodgkin lymphoma (NHL), particularly follicular and mature T/NK-cell lymphomas, is more likely to develop among patients with breast cancer, a recent study has found. Moreover, such risk is greater among those who had been treated with hormone therapy.

Breast cancer survivors at greater risk of non-Hodgkin lymphoma

03 Jan 2022

Processed food linked to multiple cancer risk

02 Jan 2022 by

Dietary intake of the common food additive nitrates and nitrites, trans fatty acids, and artificial sweeteners was associated with an increased risk of multiple cancers, according to data from the large NutriNet-Santé cohort presented at SABCS 2021.

Processed food linked to multiple cancer risk

02 Jan 2022

First chronic obstructive pulmonary disease exacerbation predicts risk of more

02 Jan 2022

First chronic obstructive pulmonary disease exacerbation predicts risk of more

02 Jan 2022

Long-term growth hormone exposure poses no risk of insulin resistance in kids born SGA

In children born small for gestational age (SGA), long-term treatment with recombinant human growth hormone (rhGH) does not carry an excess risk of insulin resistance, according to 10-year data from a study.

Long-term growth hormone exposure poses no risk of insulin resistance in kids born SGA

Chronic air pollution exposure ups MAFLD risk

Prolonged exposure to ambient air levels of particulate matter ≤1 µm (PM1), ≤2.5 µm (PM2.5), and ≤10 µm (PM10), as well as of nitrogen dioxide (NO2), appears to aggravate the likelihood of metabolic dysfunction-associated fatty liver disease (MAFLD), a recent study has found.

Chronic air pollution exposure ups MAFLD risk